Rakuten Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.76M Buy
21,634
+2,434
+13% +$607K 0.01% 262
2025
Q4
$4.66M Buy
19,200
+15,988
+498% +$4.09M 0.02% 288
2025
Q3
$95.6K Buy
+3,212
New +$877K ﹤0.01% 603
2025
Q1
$2.95M Buy
+13,421
New +$3.13M 0.01% 295
2024
Q3
$1.99M Buy
8,326
+2,069
+33% +$462K 0.01% 243
2024
Q2
$1.2M Buy
6,257
+2,302
+58% +$467K 0.01% 256
2024
Q1
$783K Buy
3,955
+3,592
+990% +$658K 0.01% 255
2023
Q4
$62.8K Buy
+363
New +$55.8K ﹤0.01% 258

Other funds holding RMD

Rakuten Investment Management's RMD Position: Q1 2026 in Review

Rakuten Investment Management increased its ResMed (RMD) stake by 13% in Q1 2026, buying an estimated $607K and bringing the position to 21,634 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #262.

Rakuten Investment Management first reported a position in RMD in Q4 2023 and has held it in 8 quarters since. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Rakuten Investment Management held 21,634 shares of ResMed worth $4.76M as of Q1 2026.
  • Rakuten Investment Management bought 2,434 ResMed shares in Q1 2026, an estimated $607K.
  • ResMed made up 0.01% of Rakuten Investment Management's portfolio in Q1 2026, its #262 holding.
  • Rakuten Investment Management first reported a position in ResMed in Q4 2023 and has held it in 8 quarters since.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.